About
Technology
Issues
FAQ
Links
Official Page
Comorbidity, age and overall survival in patients with advanced pancreatic cancer – Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.